The convergence of clinical and biomarker effects in a biomarker enriched subgroup in the Phase II ALS dataset with AP-101 is ...

Peru's electoral landscape sees unprecedented fragmentation and a voter base that appears to be turning away from the ...

BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biopharmaceutical company focused on the design and development of next-generation medicines for cancer, today announced it will ...

Clinically meaningful activity was observed in 57 patients at 400 mg BID fed, including 11.1-month median PFS and mutation-subtype–agnostic benefit across kinase versus nonkinase PIK3CA variants.

Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery and development of non-cereblon/non-VHL Targeted Glue™ degraders, today announces three upcoming presentations at the ...

ProQR’s collaboration with Eli Lilly and Company (Lilly) continued to progress in 2025, resulting in $4.5 million in ...

Actor Kevin Spacey has settled out of court in England with three men who sued him, accusing him of sexual assault.

Credit: Sam Kriegman/Northwestern University/Cover Images Engineers in the United States have created AI-powered robots that ...

Data from the ongoing PIKture-01 trial is expected to be announced in March 2026; continued enrollment in breast cancer triplet combinations ...

Azetukalner, a Kv7 potassium channel opener, reduced the frequency of focal onset seizures by a placebo-adjusted rate of 42.7 ...

Precision Bb Targeting, Robust Efficacy, Transfusion Independence, Excellent Safety in Phase II PNH Study, and Subcutaneous Administration The 12-16-week open-label study evaluated Ruxoprubart as ...

Leerink Global Healthcare Conference 2026 March 10, 2026 2:20 PM EDTCompany ParticipantsBrian Sullivan - Co-Founder, Chairman ...